journal article·2021-08Open access

Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy

Biaggio Uricoli, Lacey A. Birnbaum, Priscilla Do, James M. Kelvin, Juhi Jain, Emma Costanza, Andrew Chyong, Christopher C. Porter, Sarwish Rafiq, Erik C. Dreaden

Advanced Healthcare Materials· Volume 10· Issue 15

Abstract

Abstract Cytokine signaling is critical to a range of biological processes including cell development, tissue repair, aging, and immunity. In addition to acting as key signal mediators of the immune system, cytokines can also serve as potent immunotherapies with more than 20 recombinant products currently Food and Drug Administration (FDA)‐approved to treat conditions including hepatitis, multiple sclerosis, arthritis, and various cancers. Yet despite their biological importance and clinical utility, cytokine immunotherapies suffer from intrinsic challenges that limit their therapeutic potential including poor circulation, systemic toxicity, and low tissue‐ or cell‐specificity. In the past decade in particular, methods have been devised to engineer cytokines in order to overcome such challenges and here, the myriad strategies are reviewed that may be employed in order to improve the therapeutic potential of cytokine and chemokine immunotherapies with applications in cancer and autoimmune disease therapy, as well as tissue engineering and regenerative medicine. For clarity, these strategies are collected and presented as they vary across size scales, ranging from single amino acid substitutions, to larger protein‐polymer conjugates, nano/micrometer‐scale particles, and macroscale implants. Together, this work aims to provide readers with a timely view of the field of cytokine engineering with an emphasis on early‐stage therapeutic approaches.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Coulter Department of Biomedical Engineering Georgia Institute of Technology and Emory University Atlanta GA 30322 USA

Department of Pediatrics Emory School of Medicine Atlanta GA 30322 USA

Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta and Emory School of Medicine Atlanta GA 30322 USA

Winship Cancer Institute of Emory University Atlanta GA 30322 USA

Department of Hematology and Medical Oncology at Emory University School of Medicine Atlanta GA 30322 USA

Petit Institute for Bioengineering and Bioscience Georgia Institute of Technology Atlanta GA 30332 USA

Funding

American Cancer Society · Winship Cancer Institute · National Institutes of Health · U.S. Department of Defense · St. Baldrick's Foundation

References (100+)

Show source-provided references
1. 10.1016/j.cell.2010.01.02510.1016/j.cell.2010.01.025 ↗
2. 10.1146/annurev.cellbio.12.1.9110.1146/annurev.cellbio.12.1.91 ↗
3. 10.1182/blood-2007-03-07968110.1182/blood-2007-03-079681 ↗
4. 10.1038/nri70210.1038/nri702 ↗
5. 10.1038/s41577-019-0131-x10.1038/s41577-019-0131-x ↗
6. 10.1056/NEJM19980212338070610.1056/NEJM199802123380706 ↗
7. 10.1016/B978-0-12-800100-4.00001-510.1016/B978-0-12-800100-4.00001-5 ↗
8. 10.1016/j.addr.2017.05.01110.1016/j.addr.2017.05.011 ↗
9. 10.1200/JCO.1999.17.7.210510.1200/JCO.1999.17.7.2105 ↗
10. 10.1038/nrc125210.1038/nrc1252 ↗
11. 10.1074/jbc.R20000320010.1074/jbc.R200003200 ↗
12. 10.1038/nri258010.1038/nri2580 ↗
13. 10.1038/s41573-018-0005-010.1038/s41573-018-0005-0 ↗
14. 10.1038/s41416-018-0328-y10.1038/s41416-018-0328-y ↗
15. 10.1053/j.seminoncol.2006.06.00410.1053/j.seminoncol.2006.06.004 ↗
16. 10.1200/JCO.1986.4.6.90010.1200/JCO.1986.4.6.900 ↗
17. 10.1007/s11096-005-1319-710.1007/s11096-005-1319-7 ↗
18. 10.1038/nrrheum.2015.16710.1038/nrrheum.2015.167 ↗
19. 10.1097/00000658-198910000-0000810.1097/00000658-198910000-00008 ↗
20. 10.1097/00000658-199809000-0000410.1097/00000658-199809000-00004 ↗
21. 10.1200/JCO.2014.57.332910.1200/JCO.2014.57.3329 ↗
22. 10.3390/antib203042610.3390/antib2030426 ↗
23. 10.1016/j.immuni.2013.01.00410.1016/j.immuni.2013.01.004 ↗
24. 10.1038/cr.2016.15110.1038/cr.2016.151 ↗
25. 10.1016/j.immuni.2015.04.01510.1016/j.immuni.2015.04.015 ↗
26. 10.1038/nature1097510.1038/nature10975 ↗
27. 10.1200/JCO.1991.9.4.69410.1200/JCO.1991.9.4.694 ↗
28. 10.2214/ajr.152.4.74910.2214/ajr.152.4.749 ↗
29. 10.4049/jimmunol.120189510.4049/jimmunol.1201895 ↗
30. 10.1038/s41467-019-11782-w10.1038/s41467-019-11782-w ↗
31. 10.1002/1878-0261.1215510.1002/1878-0261.12155 ↗
32. 10.1517/14728222.2011.64861710.1517/14728222.2011.648617 ↗
33. 10.1126/science.aar324610.1126/science.aar3246 ↗
34. 10.1126/science.aar671110.1126/science.aar6711 ↗
35. 10.1056/NEJMra170616910.1056/NEJMra1706169 ↗
36. 10.1038/nrc.2016.9710.1038/nrc.2016.97 ↗
37. 10.1182/blood-2014-12-58006810.1182/blood-2014-12-580068 ↗
38. 10.1146/annurev-med-062315-12024510.1146/annurev-med-062315-120245 ↗
39. 10.1038/s41591-019-0564-610.1038/s41591-019-0564-6 ↗
40. 10.1016/j.blre.2018.11.00210.1016/j.blre.2018.11.002 ↗
41. 10.1038/s41571-019-0297-y10.1038/s41571-019-0297-y ↗
42. 10.4161/self.1.4.1390410.4161/self.1.4.13904 ↗
43. 10.1038/s41586-018-0830-710.1038/s41586-018-0830-7 ↗
44. 10.1039/c1py00034a10.1039/c1py00034a ↗
45. 10.1016/S1470-2045(19)30514-510.1016/S1470-2045(19)30514-5 ↗
46. 10.1200/JCO.2016.68.110610.1200/JCO.2016.68.1106 ↗
47. 10.1016/j.ccell.2018.10.00710.1016/j.ccell.2018.10.007 ↗
48. 10.2165/00063030-200822050-0000410.2165/00063030-200822050-00004 ↗
49. Grover P. · Cancer Stud. Ther. J. · 2019 · 4 · 1
50. 10.1088/0957-4484/24/35/35510110.1088/0957-4484/24/35/355101 ↗
51. 10.1021/jp207956710.1021/jp2079567 ↗
52. 10.1182/blood.V98.6.170810.1182/blood.V98.6.1708 ↗
53. 10.1002/cncr.2190010.1002/cncr.21900 ↗
54. 10.1200/JCO.2009.23.607510.1200/JCO.2009.23.6075 ↗
55. 10.1016/S1474-4422(14)70068-710.1016/S1474-4422(14)70068-7 ↗
56. 10.1177/009127001140706810.1177/0091270011407068 ↗
57. 10.1038/nrd103310.1038/nrd1033 ↗
58. 10.1002/anie.20050211310.1002/anie.200502113 ↗
59. 10.1021/ja504390x10.1021/ja504390x ↗
60. 10.1158/1078-0432.CCR-15-163110.1158/1078-0432.CCR-15-1631 ↗
61. 10.1158/2159-8290.CD-18-149510.1158/2159-8290.CD-18-1495 ↗
62. 10.1038/s41467-019-12901-310.1038/s41467-019-12901-3 ↗
63. 10.1158/2159-8290.CD-19-151010.1158/2159-8290.CD-19-1510 ↗
64. 10.1200/JCO.2020.38.4_suppl.63710.1200/JCO.2020.38.4_suppl.637 ↗
65. 10.1200/JCO.2020.38.15_suppl.956310.1200/JCO.2020.38.15_suppl.9563 ↗
66. 10.1200/JCO.2020.38.15_suppl.e2174410.1200/JCO.2020.38.15_suppl.e21744 ↗
67. 10.1016/j.immuni.2015.06.00310.1016/j.immuni.2015.06.003 ↗
68. 10.1021/acs.biomac.0c0026410.1021/acs.biomac.0c00264 ↗
69. 10.1186/s12967-019-2058-110.1186/s12967-019-2058-1 ↗
70. 10.1126/scitranslmed.aaw261410.1126/scitranslmed.aaw2614 ↗
71. 10.1126/scitranslmed.aau325910.1126/scitranslmed.aau3259 ↗
72. 10.1038/s41551-020-0549-210.1038/s41551-020-0549-2 ↗
73. 10.1182/blood-2017-12-82375710.1182/blood-2017-12-823757 ↗
74. 10.1158/0008-5472.CAN-12-235710.1158/0008-5472.CAN-12-2357 ↗
75. 10.1158/2326-6066.CIR-15-0093-T10.1158/2326-6066.CIR-15-0093-T ↗
76. 10.1158/1078-0432.CCR-15-141910.1158/1078-0432.CCR-15-1419 ↗
77. 10.1016/S1470-2045(18)30148-710.1016/S1470-2045(18)30148-7 ↗
78. 10.1158/1078-0432.CCR-19-335410.1158/1078-0432.CCR-19-3354 ↗
79. 10.1136/jitc-2020-00067310.1136/jitc-2020-000673 ↗
80. 10.1158/2326-6066.CIR-18-056610.1158/2326-6066.CIR-18-0566 ↗
81. 10.1073/pnas.090938410710.1073/pnas.0909384107 ↗
82. 10.1126/scitranslmed.aag318710.1126/scitranslmed.aag3187 ↗
83. 10.4049/jimmunol.150107110.4049/jimmunol.1501071 ↗
84. 10.1158/1078-0432.CCR-03-079910.1158/1078-0432.CCR-03-0799 ↗
85. 10.1158/1078-0432.CCR-19-079810.1158/1078-0432.CCR-19-0798 ↗
86. 10.1158/1078-0432.CCR-19-145210.1158/1078-0432.CCR-19-1452 ↗
87. 10.1200/JCO.2004.11.03510.1200/JCO.2004.11.035 ↗
88. 10.1186/1479-5876-7-6810.1186/1479-5876-7-68 ↗
89. 10.1158/1538-7445.AM2019-155210.1158/1538-7445.AM2019-1552 ↗
90. 10.1158/0008-5472.CAN-20-119210.1158/0008-5472.CAN-20-1192 ↗
91. 10.1158/2326-6066.CIR-17-049510.1158/2326-6066.CIR-17-0495 ↗
92. 10.1080/2162402X.2016.127730610.1080/2162402X.2016.1277306 ↗
93. 10.1002/ijc.2340810.1002/ijc.23408 ↗
94. 10.1158/1078-0432.CCR-05-280410.1158/1078-0432.CCR-05-2804 ↗
95. 10.1074/jbc.273.34.2176910.1074/jbc.273.34.21769 ↗
96. 10.1126/scitranslmed.300622110.1126/scitranslmed.3006221 ↗
97. 10.1007/s00262-014-1562-710.1007/s00262-014-1562-7 ↗
98. 10.1158/1535-7163.MCT-17-021110.1158/1535-7163.MCT-17-0211 ↗
99. 10.1093/protein/gzu01310.1093/protein/gzu013 ↗
100. 10.1158/1078-0432.CCR-08-015710.1158/1078-0432.CCR-08-0157 ↗